Table 3. SE, SP, PPV, and NPV for identifying the presence of advanced fibrosis/cirrhosis.
Biomarker test and classification | MRE fibrosis stage (‘stage ≥3 to <4’ fibrosis or higher vs. ‘stage >2 to <3’ fibrosis or lower) |
|||
---|---|---|---|---|
SE | SP | PPV | NPV | |
FIB-4 (advanced fibrosis likely vs. other) | 0.51 (0.36, 0.67) | 0.91 (0.86, 0.96) | 0.63 (0.46, 0.79) | 0.86 (0.81, 0.92) |
NFS (F3-4 vs. other) | 0.55 (0.40, 0.70) | 0.94 (0.90, 0.98) | 0.72 (0.56, 0.87) | 0.88 (0.83, 0.93) |
Confidence intervals are listed in parentheses. SE, sensitivity; SP, specificity; PPV, positive predictive value; NPV, negative predictive value; FIB-4, Fibrosis-4; NFS, NAFLD Fibrosis Score; NAFLD, non-alcoholic fatty liver disease.